The Pharmacy Times® Coronavirus Disease Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.
July 23rd 2024
Professional standard of care has judicial affirmation
July 17th 2024
Investigators found that the risk of long COVID decreased over the course of the pandemic.
July 17th 2024
The investigators note that the high prevalence of long COVID, including in pregnant individuals, emphasizes a need for health care professionals and patients to closely monitor symptoms.
July 9th 2024
Higher vaccination rates were associated with less prevalent asthmatic symptoms, but additional research is needed to confirm these findings.
June 12th 2024
Speakers at American Society of Health-System Pharmacists (ASHP) Pharmacy Futures 2024 discuss the significant increase in published clinical literature during and after the COVID-19 pandemic, and the evolving role and reliability of AI tools such as ChatGPT in providing accurate medical information.
Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults
2.0 Credits / Infectious Diseases, Respiratory, Immunization
View More
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccin...
1.25 Credits / Immunization, Infectious Diseases
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacy Technician Credit)
2.0 Credits / Immunization
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacist Credit)
2.0 Credits / Immunization
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Pharmacist’s Impact on Shingles Prevention Through Vaccination: Recommendations, Uptake, and Improved Outc...
1.5 Credits / Immunization
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
FDA Grants Emergency Use Authorization for 4-in-1 Respiratory Diagnostic Test
June 11th 2024The 4-in-1 respiratory diagnostic test is either a single nasopharyngeal or anterior nasal swab that can confirm or rule out SARS-CoV-2, influenza A virus, influenza B virus, and respiratory syncytial virus with a single test.
Read More
2 Commerce Drive
Cranbury, NJ 08512